Contrast-Enhanced Mammography (CEM) for Detecting Residual Disease after Neoadjuvant Chemotherapy: A Comparison with Breast Magnetic Resonance Imaging (MRI)

OBJECTIVE: To evaluate the performance of contrast-enhanced mammography (CEM) compared to magnetic resonance imaging (MRI) for estimating residual tumor size after neoadjuvant chemotherapy (NAC) in women with newly diagnosed breast cancer. METHODS: The institutional review board approved this study....

Descripción completa

Detalles Bibliográficos
Autores principales: Barra, Filipe Ramos, Sobrinho, Alaor Barra, Barra, Renato Ramos, Magalhães, Mayra Teixeira, Aguiar, Laira Rodrigues, de Albuquerque, Gabriela Feitosa Lins, Costa, Rodrigo Pepe, Farage, Luciano, Pratesi, Riccardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250019/
https://www.ncbi.nlm.nih.gov/pubmed/30533440
http://dx.doi.org/10.1155/2018/8531916

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250019/
https://www.ncbi.nlm.nih.gov/pubmed/30533440
http://dx.doi.org/10.1155/2018/8531916

Ejemplares similares